Camp Nou, bastion of Barcelona, opens its doors to clinical trials

Get real time updates directly on you device, subscribe now.

FC Barcelona opened the doors of their stadium for a good cause. The Catalan club has announced in a press release that Camp Nou will be made available to carry out clinical trials to combat the coronavirus.

FC Barcelona actively takes part in the fight against the COVID-19 pandemic. In this sense, the giant of Liga, which closed Camp Nou since the stop of football because of the pandemic has reopened its stadium exceptionally for a clinical trial.

It took this initiative to help find a preventive treatment with hydroxychloroquine as part of the fight against the coronavirus pandemic which is severely affecting Spain.

The club said in a statement, Camp Nou will be the fourth sample collection space. The other collection points are located in the parking lot of the German Trias I Pujol Hospital in Badalona, ​​in the Club Natació Sabadell and in a service station on Avenida Meridiana in Barcelona.

 
“The aim is to check whether this medicine prevents people who have been in contact with an infected person from developing the disease or from doing so more lightly,” said the Spanish champion club. 
 

“The project has been approved by the Catalan Department of Health and the Spanish Medicines Agency, and is being implemented with the approval of the World Health Organization,” said the La Liga club.

The trial aims to test the effectiveness of preventive treatment with hydroxychloroquine, a drug used to prevent malaria. The goal is to find out if this medication prevents people who have been in contact with infected people from developing the disease.

Directed by doctors Oriol Mitjà and Bonaventura Clotet, the project includes the participation of the Germans Trias hospital, the Iris-Caixa Institute for AIDS research, the Catalan Health Institute, the health department of the Generalitat, of the Center for Epidemiology Studies on STIs and AIDS in Catalonia (CEEISCAT), and the Rubió and Gebro laboratories.

Dr. Mitjà said “If the validity of the treatment is checked, an additional avenue will be opened for the control of the coronavirus epidemic worldwide. The strategy could reduce community transmission of the new virus, which has a significant benefit in terms of lives saved”.

“It would also involve changes to administrative segregation and mobility measures, which would reduce the economic impact of the pandemic,” he adds.

Get real time updates directly on you device, subscribe now.

Loading...